MediWound Ltd.
General ticker "MDWD" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $197.2M (TTM average)
MediWound Ltd. follows the US Stock Market performance with the rate: 21.2%.
Estimated limits based on current volatility of 4.1%: low 16.17$, high 17.54$
Factors to consider:
- Total employees count: 63 as of 2014
- Price in estimated range
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [10.41$, 23.36$]
- 2025-12-31 to 2026-12-31 estimated range: [9.01$, 20.73$]
Financial Metrics affecting the MDWD estimates:
- Negative: with PPE of -7.3 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -7.81 <= 0.04
- Positive: Inventory ratio change, % of -1.42 <= -0.76
- Positive: Interest expense per share per price, % of 0.32 <= 0.74
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: -14.19 < Investing cash flow per share per price, % of -4.81
Short-term MDWD quotes
Long-term MDWD plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $26.50MM | $18.69MM | $20.22MM |
| Operating Expenses | $34.16MM | $34.19MM | $39.60MM |
| Operating Income | $-7.66MM | $-15.50MM | $-19.38MM |
| Non-Operating Income | $-11.86MM | $8.97MM | $-10.78MM |
| Interest Expense | $0.16MM | $0.34MM | $0.56MM |
| R&D Expense | $9.61MM | $7.07MM | $8.25MM |
| Income(Loss) | $-19.52MM | $-6.53MM | $-30.16MM |
| Taxes | $0.08MM | $0.18MM | $0.06MM |
| Profit(Loss)* | $-19.60MM | $-6.72MM | $-30.22MM |
| Stockholders Equity | $10.91MM | $31.59MM | $31.15MM |
| Inventory | $1.96MM | $2.85MM | $2.69MM |
| Assets | $50.02MM | $66.46MM | $73.50MM |
| Operating Cash Flow | $-11.88MM | $-10.46MM | $-13.62MM |
| Capital expenditure | $0.56MM | $6.46MM | $6.27MM |
| Investing Cash Flow | $-0.48MM | $-34.32MM | $-8.40MM |
| Financing Cash Flow | $35.76MM | $22.92MM | $19.39MM |
| Earnings Per Share** | $-3.93 | $-0.75 | $-3.03 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.